---
title: "CMPS: COMP360 targets a 2027 launch, offering rapid, durable relief for TRD and advancing a PTSD program"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295675963.md"
description: "COMP360 is advancing toward a Q4 NDA filing, with FDA review and DEA rescheduling expected to enable a first-half 2027 launch. The product offers rapid, durable relief for treatment-resistant depression, with a favorable safety profile and strong payer interest. A late-stage PTSD program is also progressing.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-12T13:55:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295675963.md)
  - [en](https://longbridge.com/en/news/295675963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295675963.md)
generator: "portal-rs"
---

# CMPS: COMP360 targets a 2027 launch, offering rapid, durable relief for TRD and advancing a PTSD program

COMP360 is advancing toward a Q4 NDA filing, with FDA review and DEA rescheduling expected to enable a first-half 2027 launch. The product offers rapid, durable relief for treatment-resistant depression, with a favorable safety profile and strong payer interest. A late-stage PTSD program is also progressing.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CMPS.US](https://longbridge.com/en/quote/CMPS.US.md)

## Related News & Research

- [Odyssey Behavioral Healthcare Marks 10 Years with Measurable Clinical Outcomes Across Mental Health, Substance Use and Eating Disorder Programs](https://longbridge.com/en/news/297943522.md)
- [09:40 ETODG by MCG Expert Joins Workers' Comp Experts for Panel Discussion on Claims Consistency at National Comp 2026](https://longbridge.com/en/news/297662064.md)
- [Gene Munster Gives AAPL's New CEO John Ternus a $50 Million Challenge on Day One — ‘The Payoff Would Be Immediate on Multiple Levels'](https://longbridge.com/en/news/297755831.md)
- [Is Vertex Pharmaceuticals (VRTX) Undervalued Following Casgevy’s FDA Label Expansion?](https://longbridge.com/en/news/297989826.md)
- [WOOF: Q2 2026 delivered stable sales, improved margins, and higher EBITDA, with guidance reaffirmed](https://longbridge.com/en/news/297824838.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**